Literature DB >> 10536173

EXTL3/EXTR1 alterations in colorectal cancer cell lines.

T Arai1, Y Akiyama, H Nagasaki, N Murase, S Okabe, T Ikeuchi, K Saito, T Iwai, Y Yuasa.   

Abstract

We previously demonstrated that metastasis-related tumor suppressor gene(s) may exist on chromosome 8p21-22 on allelotype analysis of early colorectal carcinomas (CRC) with lymph node metastasis. Here, we searched for target gene(s) in this chromosomal region in the UniGene database. The EXTL3 (also called EXTR1) gene was selected as a candidate because of its homology to EXT1 and EXT2, putative tumor suppressor genes. We screened 12 CRC cell lines for mutations by means of polymerase chain reaction (PCR)-single strand conformation polymorphism. Three cell lines showed EXTL3 mutations, all of which were located within exon 3 and caused amino acid substitutions. Reverse transcription-PCR analysis showed that the EXTL3 expression was lacking in 1 of the 12 colorectal cancer cell lines. Although there is still no definitive evidence that EXTL3 is a tumor suppressor gene for CRC, these data suggest that inactivation of the EXTL3 gene may at least offer a selective growth advantage for some CRC cell lines.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10536173     DOI: 10.3892/ijo.15.5.915

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  4 in total

1.  Human tumor suppressor EXT gene family members EXTL1 and EXTL3 encode alpha 1,4- N-acetylglucosaminyltransferases that likely are involved in heparan sulfate/ heparin biosynthesis.

Authors:  B T Kim; H Kitagawa; J Tamura ; T Saito; M Kusche-Gullberg; U Lindahl; K Sugahara
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-05       Impact factor: 11.205

2.  Multiple osteochondromas: clinicopathological and genetic spectrum and suggestions for clinical management.

Authors:  Liesbeth Hameetman; Judith Vmg Bovée; Antonie Hm Taminiau; Herman M Kroon; Pancras Cw Hogendoorn
Journal:  Hered Cancer Clin Pract       Date:  2004-11-15       Impact factor: 2.857

3.  EXTL2, a member of the EXT family of tumor suppressors, controls glycosaminoglycan biosynthesis in a xylose kinase-dependent manner.

Authors:  Satomi Nadanaka; Shaobo Zhou; Shoji Kagiyama; Naoko Shoji; Kazuyuki Sugahara; Kazushi Sugihara; Masahide Asano; Hiroshi Kitagawa
Journal:  J Biol Chem       Date:  2013-02-10       Impact factor: 5.157

Review 4.  Heparan sulfate proteoglycans and cancer.

Authors:  F H Blackhall; C L Merry; E J Davies; G C Jayson
Journal:  Br J Cancer       Date:  2001-10-19       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.